Feedback / Questions
entinostat (SNDX-275) - Kyowa Hakko Kirin, Syndax
Entinostat: NDA submission in combination with exemestane for HR+ metastatic breast cancer in 2020
(Syndax)
-
Aug 8, 2019 -
Q2 2019 Results
NDA
http://ir.syndax.com/static-files/96fb80dc-d47d-4792-9bf8-5cfe4d02d30c
Aug 8, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious